The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1977 • 337 citations

Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

1968 • 249 citations

Altered helper and suppressor lymphocyte populations in surgical patients

1984 • 153 citations

Augmentation of the human immune response by cyclophosphamide.

1982 • 136 citations

Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea Pig**From the Department of Dermatology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104.

1967 • 133 citations

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.

1984 • 124 citations

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.

1982 • 104 citations

Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes

1983 • 68 citations

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.

1985 • 53 citations

T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease

1983 • 35 citations

The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer

1985 • 33 citations